6:33AM On The Wires (WIRES) : Sinovac Biotech (SVA) announced that Sinovac Beijing, the main operating subsidiary co of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products from the China State and Food Administration for its proprietary vaccines, its Haidian district bulk production plants, and its Changping filing and packaging facility. The GMP certificate is valid for five years starting from April 17, 2013.
Recent SVA News
- SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 • Business Wire • 04/30/2026 01:22:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 10:10:11 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:34:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:29:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:28:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:10:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:06:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:24:16 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/30/2026 08:24:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:24:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:47 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/30/2026 08:23:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 08:23:19 PM
- SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing • Business Wire • 01/22/2026 11:00:00 AM
- SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement • Business Wire • 01/04/2026 03:13:00 PM
- Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report • Business Wire • 01/04/2026 03:00:00 PM
- 安提瓜法院作出临时裁决:授予董事会在2025 年股东会议争议案庭审前对公司的控制权 • Business Wire • 12/17/2025 12:01:00 PM
- Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting • Business Wire • 12/17/2025 12:00:00 PM
- /C O R R E C T I O N -- Heng Ren Partners/ • PR Newswire (US) • 11/12/2025 03:32:00 AM
- /C O R R E C T I O N -- Heng Ren Partners/ • PR Newswire (US) • 11/11/2025 11:40:00 PM
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment • PR Newswire (Canada) • 11/11/2025 10:00:00 PM
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment • PR Newswire (US) • 11/11/2025 10:00:00 PM
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment • PR Newswire (US) • 11/11/2025 10:00:00 PM

